A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT

[1]  E. Puchhammer-Stöckl,et al.  Validation of plasma Torque Teno viral load applying a CE-certified PCR for risk stratification of rejection and infection post kidney transplantation. , 2022, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[2]  E. Puchhammer-Stöckl,et al.  Integrated Immunologic Monitoring in Solid Organ Transplantation: The Road Toward Torque Teno Virus-guided Immunosuppression , 2022, Transplantation.

[3]  H. Putter,et al.  Torque teno virus loads after kidney transplantation predict allograft rejection but not viral infection. , 2021, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[4]  E. Puchhammer-Stöckl,et al.  Torque Teno Virus Load Is Associated With Subclinical Alloreactivity in Kidney Transplant Recipients: A Prospective Observational Trial , 2020, Transplantation.

[5]  A. Großhennig,et al.  Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial. , 2020, Journal of the American Society of Nephrology.

[6]  E. Puchhammer-Stöckl,et al.  Torque teno viral load reflects immunosuppression in paediatric kidney-transplanted patients—a pilot study , 2020, Pediatric Nephrology.

[7]  S. Bakker,et al.  Torquetenovirus Serum Load and Long-Term Outcomes in Renal Transplant Recipients , 2020, Journal of clinical medicine.

[8]  E. Albert,et al.  Early kinetics of Torque Teno virus DNA load and BK polyomavirus viremia after kidney transplantation , 2019, Transplant infectious disease : an official journal of the Transplantation Society.

[9]  S. Fafi-Kremer,et al.  Torquetenovirus viremia for early prediction of graft rejection after kidney transplantation. , 2019, The Journal of infection.

[10]  G. Duverlie,et al.  No correlation between Torque Teno virus viral load and BK virus replication after kidney transplantation. , 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[11]  G. Antonelli,et al.  Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence , 2019, Journal of medical virology.

[12]  E. Puchhammer-Stöckl,et al.  Torque Teno Virus for Risk Stratification of Acute Biopsy-Proven Alloreactivity in Kidney Transplant Recipients , 2019, The Journal of infectious diseases.

[13]  E. Albert,et al.  Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression‐related complications after kidney transplantation , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  U. Christians,et al.  Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report , 2019, Therapeutic drug monitoring.

[15]  C. Scagnolari,et al.  Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients , 2018, Scientific Reports.

[16]  C. Scagnolari,et al.  Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients , 2018, Scientific Reports.

[17]  E. Puchhammer-Stöckl,et al.  Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients , 2018, The Journal of infectious diseases.

[18]  Deepali Kumar,et al.  Evaluation of a Novel Global Immunity Assay to Predict Infection in Organ Transplant Recipients , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  D. Abramowicz,et al.  Recent advances in kidney transplantation: a viewpoint from the Descartes advisory board* , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  M. Naesens,et al.  Precision Transplant Medicine: Biomarkers to the Rescue. , 2017, Journal of the American Society of Nephrology : JASN.

[21]  P. Marquet,et al.  Establishing Biomarkers in Transplant Medicine: A Critical Review of Current Approaches. , 2016, Transplantation.

[22]  N. Mueller,et al.  Risk Stratification for Rejection and Infection after Kidney Transplantation. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[23]  T. Lazzarotto,et al.  Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial , 2015, Transplantation.

[24]  U. Boggi,et al.  Short-term kinetics of torque teno virus viraemia after induction immunosuppression confirm T lymphocytes as the main replication-competent cells. , 2015, The Journal of general virology.

[25]  N. Neff,et al.  Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy , 2013, Cell.

[26]  W. Weimar,et al.  Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized‐Controlled Clinical Trials † , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[27]  P. Halloran,et al.  Reduced exposure to calcineurin inhibitors in renal transplantation. , 2007, The New England journal of medicine.

[28]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..